This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| TG 21.11 | |
|---|---|
| Name | TG 21.11 |
| Type | Technical guideline |
| Subject | Radiation dosimetry and quality assurance |
| Issued by | Task Group 21.11 |
| Jurisdiction | International |
| Date | 2000s |
TG 21.11
TG 21.11 is a technical guideline prepared by an expert task group to provide standardized procedures for radiation measurement, calibration, and quality assurance in clinical and research settings. It synthesizes consensus practices from panels and institutions such as the International Commission on Radiation Units and Measurements, International Atomic Energy Agency, American Association of Physicists in Medicine, National Institute of Standards and Technology, and national metrology laboratories, and aligns with international protocols like the IAEA TRS-398, AAPM TG-51, and ISO standards. The document bridges measurement science practiced at laboratories like Physikalisch-Technische Bundesanstalt and National Physical Laboratory with clinical implementation at hospitals and radiotherapy centers affiliated with universities such as Harvard University, University of Pennsylvania, and University of Oxford.
TG 21.11 provides a framework for traceable dosimetry, addressing primary standards, secondary standards, and transfer instrumentation used across modalities including teletherapy units, linear accelerators, brachytherapy sources, and imagining systems. It situates measurement techniques alongside calibration hierarchies exemplified by organizations like the Bureau International des Poids et Mesures, Physikalisch-Technische Bundesanstalt, and National Institute for Biological Standards and Control, and references historical protocols such as TG-21 and contemporary successors like TG-51. The guideline was developed through consultation with stakeholder bodies including the World Health Organization, European Society for Radiotherapy & Oncology, and national regulatory authorities like the U.S. Nuclear Regulatory Commission and Health Canada.
The purpose of TG 21.11 is to harmonize procedures for absorbed dose determination, measurement uncertainty estimation, and cross-institutional comparability for clinics, calibration laboratories, and manufacturers like Varian Medical Systems, Elekta, and Ion Beam Applications. Its scope encompasses photon, electron, and proton beams, sealed source calibrations for radionuclides such as Iridium-192, Cesium-137, and Iodine-125, and procedures for reference-class detectors produced by vendors like PTW and Standard Imaging. The guideline targets medical physicists, clinical engineers, calibration scientists, and inspectors from institutions such as Johns Hopkins Hospital, Mayo Clinic, and national metrology institutes.
TG 21.11 prescribes methods for chamber calibration, beam quality specification, phantom design, and measurement geometry drawing on established techniques from the National Physical Laboratory and protocols used at centers like Cleveland Clinic and MD Anderson Cancer Center. It specifies use of ionization chambers traceable to standards maintained by bodies like the National Institute of Standards and Technology and recommends electrometers and electrometer calibration consistent with practices at Sandia National Laboratories and Los Alamos National Laboratory. Procedures cover perturbation corrections, recombination corrections, and temperature-pressure corrections referencing experimental methodologies reported by groups at Lawrence Berkeley National Laboratory and Forschungszentrum Jülich.
The guideline outlines standardized reporting templates that clinics can adopt to present absorbed dose, uncertainty budgets, and calibration histories, facilitating peer review by institutions such as American College of Radiology, European Federation of Organisations for Medical Physics, and national accreditation agencies like The Joint Commission. Reporting elements include measurement conditions, calibration chain linked to metrology institutes like CSIR-NPL and KRISS, and comparison metrics used in intercomparisons conducted by organizations like the IAEA Dosimetry Laboratory and regional quality assurance networks. TG 21.11 emphasizes transparency to support audits by regulators such as Food and Drug Administration and oversight bodies like Office for Nuclear Regulation.
Validation procedures in TG 21.11 recommend internal quality control checks, external audits, and participation in intercomparison exercises run by the IAEA, European Association of Nuclear Medicine, and national proficiency testing providers. The guideline details acceptance criteria, control chart approaches inspired by statistical practices at National Institute for Occupational Safety and Health and European Committee for Standardization, and root-cause analysis procedures used in healthcare systems at Kaiser Permanente and NHS England. It encourages cross-validation using independent detectors, phantom-based end-to-end tests, and retrospective review procedures adopted by clinical research centers such as Dana-Farber Cancer Institute.
TG 21.11 interfaces with regulatory frameworks and accreditation requirements enforced by authorities like the U.S. Nuclear Regulatory Commission, Food and Drug Administration, Health Canada, and European Medicines Agency. It supports compliance with directives and standards such as Council Directive 2013/59/Euratom, IEC 60601, and national dosimetry regulations, providing documentation templates useful for licensure inspections at hospitals and industrial sites like those of Siemens Healthineers and GE Healthcare. The guideline assists manufacturers, clinics, and laboratories in meeting obligations under national metrology laws and international recommendations promulgated by bodies including the International Atomic Energy Agency and World Health Organization.
Applications of TG 21.11 span clinical radiotherapy commissioning at centers like Royal Marsden Hospital and Peter MacCallum Cancer Centre, brachytherapy program setup at institutions such as Memorial Sloan Kettering Cancer Center, and proton therapy facility validation at Paul Scherrer Institute and Francis H. Burr Proton Therapy Center. Case studies illustrate implementation in quality assurance programs for multi-institution trials coordinated by groups like Radiation Therapy Oncology Group and European Organisation for Research and Treatment of Cancer and in national dosimetry audits administered by agencies such as NPL and the IAEA. Outcomes reported include improved inter-center dose agreement, reduced systematic errors in complex treatments like IMRT and VMAT, and enhanced confidence in clinical trial dosimetry.
Category:Radiation dosimetry guidelines